Healthy Skepticism Library item: 7293
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: news
Zehr L.
Cholesterol drug companies under the gun as patents expire
The Globe and Mail 2006 Oct 10
http://www.theglobeandmail.com/servlet/Page/document/v5/content/subscribe?user_URL=http://www.theglobeandmail.com%2Fservlet%2Fstory%2FLAC.20061010.RCHOLESTEROL10%2FTPStory%2FBusiness&ord=1166943523349&brand=theglobeandmail&force_login=true
Abstract:
A shakeup is swirling through the cholesterol market, one of the most profitable for the drug industry in recent years, as two mainstays have been hit by generic competition this year and giant Pfizer Inc. is rushing to protect its Lipitor franchise.
